​Last updated on 24 April 2024

Recent key changes:

  • Update in the return mechanism of Faecal Immunochemical Test (FIT) kit samples to the SFL-appointed laboratory for Colorectal Cancer Screening with effect from 1 April 2024.

Cancer is the leading cause of​ death in Singapore, accounting for nearly 1 in 3 deaths.1 Early detection and prompt treatment of these cancers through screening results in better outcomes and survival.

Table 1: Most Common Cancers and Cancer Deaths By Type​ From 2017 To 20211

Most Common Cancers by Type

Most Common Cancer Deaths by Type


1. Prostate – 16.8%

2. Colorectal – 16.3%

3. Lung – 13.5%

1. Lung – 24.8%

2. Colorectal – 14.4%

3. Liver – 12.5%


1. Breast – 29.7%

2. Colorectal – 12.9%

3. Lung – 7.3%

1. Breast – 17.2%

2. Colorectal – 15.6%

3. Lung – 14.9%


Regular screening of selected cancers in asymptomatic individuals assessed to be clinically and cost effective can be offered to those eligible in the general population. The individual's past medical history and family history may also determine whether screening should be offered on a case-by-case basis.

This care protocol focuses on Category 1 screening recommendations made by the Screening Test Review Committee (STRC) ​ where there is robust evidence that screening is clinically and cost effective for use at the population level. Currently, screening for three cancers (i.e., Breast, Cervical and Colorectal) are recommended for general population screening. Government subsidies are available under the Screen For Life (SFL) Programme​ – details are in the Financing section.

Table 2: STRC recommended screening tests for cancer in the general population where SFL ​subsidies apply​2

Eligible Popu​lation
​Screening Meth​od
Br​east Cancer
Asympt​omatic 50–69 year-​​old women

(Note:​ Those aged 40-49 ​years old and those above 69 years old and above may be offered screening under SFL based on their risk profile.^ To avail SFL subsidies, please click here for further details.)


50–​69 years

​Every 2 years


(Women aged 40–49 years old may be offered annual screening if assessed to be of higher risk ​) 

Cervical Cancer

Any female who has ever had sexual intercourse​

​Pap test

25–29 years

​Every 3 years
​HPV DNA test

30 years and above

​Every 5 years

Colorectal Cancer​

​(a) Asymptomatic individuals who do not have a family history of colorectal cancer;

(b) Asymptomatic individuals with positive family history confined to non-first-degree relatives or relatives older than 60 years old.​

For special populations, please click here 

​Faecal Immuno-chemical Test (FIT) x2



50 years and above​


(Note: Not covered under SFL. GP should discuss with patient the benefits and disadvantages of colonoscopy.)

​​​50 years and above​

Every 5–10 years

^For women who are 40​49 years old and >69 years old, a discussion on risks and benefits of breast cancer screening should be conducted as part of the Health Plan and a recommendation made for the individual patient to proceed (or not proceed) with mammography based on this discussion.​

Please note that other screening modalities such as breast MRI for breast cancer screening, and Computed Tomography (CT) Colonography and Faecal Immunochemical Test (FIT)-DNA test for colorectal cancer screening, are not recommended for general population screening but only for those at higher risk. Tests such as tumour markers for breast and colorectal cancer, or imaging studies such as ultrasound of the breast or pelvis, CT pelvis or abdomen, are not recommended for screening and should only be used for diagnostic purposes in patients. ​​

GPs should proactively check if their enrolled patients have undergone the nationally recommended cancer screening tests, in line with the schedule described in Table 2. If they have not done so, GPs should encourage their patients to do so. GPs may conduct the screening where appropriate or refer patients to private or public sector screening providers where breast, cervical or colorectal screening is offered, according to patients' preference. If the patient has completed their screening with providers not within Public Healthcare Institutions (PHIs) (e.g. as part of workplace screening), GPs should request that the patient share the results with them.  Where tests were performed within PHIs, GPs may refer to NEHR for the results of their patients. 

Due to the different nature of the tests involved (i.e. breast imaging, stool collection, cervical cancer screening test), patients must be made aware of the steps involved, including when the results will be available or when the screening provider is expected to provide the result to the requesting GP.

As part of good clinical practice, GPs should proactively check for results of screening tests ordered. The relevant cancer screening results can be found in NEHR under the Screening Tab . GPs should follow-up with patients on their screening results accordingly, particularly those with abnormal results, and encourage timely intervention. 

Colorectal Cancer Screening under SFL

CHAS GPs can order FIT kits from HPB's appointed vendor  for distribution to patients in their clinic. With effect 1 April 2024, when distributing the kits to patients, GPs should remind patients to promptly return their samples to the clinic within 2 weeks. After patients have collected their stool samples (2-day sampling), they should return their samples to the CHAS GP clinic from which they have collected their kit. CHAS GP clinics should contact the SFL-appointed lab  for the sample collection and these samples will be picked up from the CHAS GP clinics by the SFL-appointed lab courier for processing. 

The patient's FIT results will be sent to the clinic within 2 weeks. 

For Normal Results

GPs are encouraged to follow up via face-to-face or tele-consult to close the screening episode, including advising patient on their next screening cycle. 

For Abnormal Results​

CHAS GPs should provide patients with appropriate counselling and encourage patients to attend their follow-up appointments, which will be scheduled by HPB's programme coordinators. Programme coordinators will contact patients with abnormal results directly to schedule a follow-up appointment at the respective participating Assessment Centres for colorectal cancer assessment . CHAS GPs should not make appointments to the Assessment Centres for patients who did their screening under SFL (i.e. used FIT kits ordered from HPB's appointed vendor), regardless of CHAS/PG/MG status.

Refer to HPB's Referral Pathway for Patients with Abnormal FIT Results. 

Breast Cancer Screening

Breast cancer screening can be done at any one of the SFL Breast Cancer screening centres  and patients should make an appointment with the screening centre before visiting.

For women who are 40​49 years old and >69 years old, a risk-benefit discussion is recommended by the STRC to precede breast cancer screening. This discussion should be carried out between GP and patient as part of the Health Plan, and a tailored recommendation for mammography made on the basis of this discussion. This discussion can be documented by the GP in the Health Plan (as a free text field). GPs are strongly encouraged to issue a referral form for mammograms​. A complete referral form ensures that patients receive both SFL and Healthier SG subsidies and facilitates the flow of screening results back to the referring GP for appropriate follow-up with the patient.

GPs should remind patients to bring the hardcopy referral form to their mammography appointment. After the patient has been screened, the breast cancer screening centre will mail the screening results back to the patient within 4-6 weeks. If a referral form was provided by the referring GP and presented by the patient upon registration for screening, the screening results will also be mailed to the referring GP. Otherwise, GPs can also view patients' results in NEHR.

For Normal Results

GPs are encouraged to follow up via face-to-face or tele-consult to close the screening episode, including advising the patient on their next screening cycle, based on the recommended frequency in Table 2​.

For Abnormal Results

The screening result letter will inform the patient about the participating Assessment Centre  that they should make an appointment with within two weeks for further investigations. GPs are encouraged to provide patients with appropriate counselling and encourage patients to book and attend their follow-up appointment with the Assessment Centre as early as possible. This may be done opportunistically or via a phone/video call. 

If no appointment has been made in 2 weeks, the Assessment Centre will send a reminder to the patient. If no follow-up action is recorded after 2 months, HPB will telephone the patient as a final reminder.

Cervical Cancer Screening

Subsidised Pap tests and HPV DNA tests are available at CHAS GPs.

However, should the patient request to undertake the cervical cancer screening at a clinic other than their enrolled Healthier SG GP (e.g. if the patient prefers the screening to be done by a female healthcare professional and this is unavailable at the enrolled Healthier SG GP), GPs may arrange for the patient to be referred to another CHAS GP that is able to offer the cervical cancer screening. As part of good, professional and collegiate relationships, we encourage GPs to refer to a fellow female Healthier SG GP with whom there have been prior arrangements. Alternatively, GPs may contact their respective PCN HQs for assistance. PCN HQs will maintain a list of female CHAS GPs who are willing to accept such referrals.  

In such instances, enrolling GPs should issue a referral form to the swabbing GP to ensure that the patient receives a waiver of co-payment under Healthier SG. An updated CHAS (Medical) Referral Form has been made available to Healthier SG GP clinics as of 5 July 2023 for this purpose. GPs should not refer to polyclinics as the patient will not be eligible for fully subsidised cervical cancer screening there.

After the patient has been screened, labs will send the screening results to the GP within 7 calendar days. If the patient was referred by his enrolling GP to another CHAS GP for screening, the results will be mailed to the swabbing GP.

For Normal Results

GPs are encouraged to follow up via face-to-face or tele-consult to close the screening episode, including advising the patient on their next screening cycle, based on the recommended frequency in Table 2.

If the patient was referred to another GP clinic, the onus is on the swabbing GP to follow up with the patient. Referring GPs can access results on NEHR to facilitate health planning for their enrolled patients. 

For Abnormal Results

The timeline for conducting the repeat screening/follow-up is indicated in Table 3. If the patient was referred to another GP clinic for screening, the onus is on the swabbing GP to follow-up with patients for abnormal results, including making a referral to participating SFL cervical cancer screening Assessment Centres  . GPs should remind patients to make their own appointment with the Assessment Centre.

Table 3: Timeline for Conducting the Repeat Cervical Cancer Screening/Follow-up

Screening Tests Eligibility 1st Repeat (if indicated) 2nd Repeat (if indicated) Follow up
Pap Test (up to 2 repeat tests) As per screening eligibility To be conducted no later than 12 months after initial screening visit date To be conducted no later than 12 months after first repeat test To be conducted no later than 6 months after last screening visit date

HPV Test (up to 1 repeat test)
​As per screening eligibility
​To be conducted no earlier than 9 months from, and no later than 18 months after, initial screening visit date.
​To be conducted no later than 6 months after last screening visit date

Click the blue information icons in Table 4 to see management workflows and referral recommendations under SFL for abnormal Pap test and HPV test results.

Table 4: Management of Abnormal Results

For Abnormal Pap Test Results
  1. Management of cervical cytology screening 
  2. Management of unsatisfactory cytology results 
  3. Management of abnormal cytology results with no past history of CIN or genital tract cancer 
For Abnormal HPV Test Results
  1. Possible outcomes of HPV test and the corresponding follow-up actions and potential benefits 

GPs may make subsidised referrals for patients to follow up at the participating SFL Assessment Centres , if they fulfill the following criteria:

  1. ​Singapore Citizens including non-CHAS/non-PG/non-MG cardholders, who are eligible for screening and follow-up under SFL; and
  2. Found to have any abnormal cervical cancer screening Pap test and HPV test results under SFL and require a referral to an Assessment Centre  for treatment and care management 

GPs may also refer patients with clinically suspicious looking cervix to Assessment Centres for subsidised follow-up, regardless of the cervical cancer screening result.

GPs may use the CHAS (Medical) Referral Form​ to make subsidised referrals to Assessment Centres. The referral form can also be found in Healthier SG-compatible CMS and on the PCDS web-portal. GPs should tick "SFL" under the item named "Is this referral related to a CHAS/SFL/VCDSS visit?". The actual subsidy status will be determined by prevailing SFL eligibility.

CHAS GPs should provide eligible patients with i) a completed CHAS (Medical) Referral Form​, ii) the relevant lab results, and advise them to bring these documents with them for their appointment, along with their NRIC.

The following data fields should be documented in GPs' case notes as part of good clinical practice for all patients enrolled to their practice. 
Submission of data fields marked with asterisks* is required for Healthier SG Annual Service Fee payments. 

For private screenings not directly ordered/ performed by the GPs, in order to qualify for Annual Service Fees, enrolling GPs must have sight over the results and retain a record of the results as part of appropriate care practice.  These can be submitted via your Healthier SG-compatible CMS or the PCDS.

  1. Screening Type*
    • Colorectal Cancer: FIT/Colonoscopy
    • Cervical Cancer: Pap/HPV DNA test
    • Breast cancer: Mammogram
  2. Date of Screening*
  3. Follow-up Outcome*
  4. Screening Exceptional Condition(s) (if applicable)*
  5. I acknowledge that I have reviewed the results and care delivery provided, that the screenings done are clinically indicated as per MOH's prevailing guidelines

Fully-Subsidised Screening Tests under Healthier SG

For Singapore Citizens (SCs) enrolled in Healthier SG, the mammogram for breast cancer screening, the FIT for colorectal cancer screening and the Pap/HPV test for cervical cancer screening will be fully subsidised when conducted or referred by their enrolled GP, if conducted in line with the schedule and eligibility criteria laid out in Table 2. This includes repeat tests if needed for cervical cancer screening. Healthier SG GPs therefore do not need to collect payments from SCs enrolled to their clinics. For FIT and Pap/HPV tests, Healthier SG GPs should claim for the full subsidy amount using the same process and to the same bank account as for payments made under the SFL scheme.  GPs are advised to check the enrollee's eligibility for the screening subsidies using the subsidy eligibility tool for SFL in the MOH Healthcare Claims Portal​.

Details on GP remuneration for providing SFL screenings to eligible SCs can be found in the prevailing CHAS agreement.  Details on the GP Annual Service Fee can be found in the Healthier SG Enrolment Programme Agreement.